// App-Quantinova.ai

: Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Researchers

Presenter

  • Noga Shem-Tov

Principal Investigators

  • Christophe Peczynski

  • Myriam Labopin

  • Maija Itl-Remes

  • Didier Blaise

  • Hlne Labussire-Wallet

  • Grard Soci

  • Nicolaus Krger

  • Per Ljungman

  • Boris Afanasyev

  • Patrice Chevallier

  • Johanna Tischer

  • Grzegorz Helbig

  • Pavel Jindra

  • Sebastian Giebel

  • Mohamad Mohty

  • Arnon Nagler

Medical Centers

  • Hematology and BMT Division, Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Ramat-Gan, Israel

  • Acute Leukemia Working Party of EBMT, Paris, France, Paris, France

  • Stem Cell Tranplant Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  • Service d'Hematologie, Centre Hospitalier, Lyon-Sud, France

  • Department of Hematology and Transplantation Unit, APHP Saint Louis Hospital, Paris, France

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

  • Pavlov First Saint Petersburg State Medical University, Saint‐Petersburg, Russian Federation

  • Pediatric Hematology, Nantes University Hospital, Nantes, France

  • Klinikum Grosshadern, Munich, Germany

  • Silesian Medical Academy, University Department of Haematology and BMT, Katowice, Poland

  • Charles University Hospital, Plzen, CZE

  • Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland,

  • EBMT Paris study office / CEREST-TC, Saint Antoine Hospital, Paris, France,

  • Hematology Department, Hopital Saint Antoine, Service dHematologie et Therapie Cellulaire, Paris, France

  • Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Locations

  • Israel

  • France

  • Finland

  • Germany

  • Sweden

  • Russia

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved